Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 30
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

NANJING KING-FRIEND

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 29
  • 0 comments

FDA approve PALONOSETRON HYDROCHLORIDE

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 32
  • 0 comments

FDA approve PEMBROLIZUMAB

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 31
  • 0 comments

FDA approve ICATIBANT ACETATE

Comment Full text

NEXUS PHARMS

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 29
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

DELCATH SYSTEMS INC

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 31
  • 0 comments

FDA approve MELPHALAN HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 32
  • 0 comments

FDA approve CLOZAPINE

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 27
  • 0 comments

FDA approve ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE

Comment Full text

BAUSCH AND LOMB

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 30
  • 0 comments

FDA approve DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE

Comment Full text

MSN

  • FDA Approval
  • Aug. 22, 2023, 11:02 UTC
  • 31
  • 0 comments

FDA approve LOSARTAN POTASSIUM

Comment Full text
  • Previous
  • 715
  • 716
  • 717
  • 718
  • 719
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5289)
  • SEC News(250709)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150010)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin